Can-Fite BioPharma Ltd. Depreciation
Can-Fite BioPharma Ltd. (CANF) reported Depreciation of $24.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-26
| Period end | Depreciation 12 month |
|---|---|
| 2025-12-31 | $24.00K 20-F · filed 2026-03-26 |
| 2024-12-31 | $7.00K 20-F · filed 2026-03-26 |
| 2023-12-31 | $15.00K 20-F · filed 2026-03-26 |
| 2022-12-31 | $14.00K 20-F · filed 2025-04-14 |
| 2021-12-31 | $14.00K 20-F · filed 2024-03-28 |
| 2019-12-31 | $14.00K 6-K · filed 2020-06-01 |
| 2018-12-31 | $14.00K 6-K · filed 2020-06-01 |
| 2017-12-31 | $19.00K 6-K · filed 2020-06-01 |